📰 Therapeutic Development Programs News
Page 2 - Therapeutic Development Programs News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Therapeutic Development Programs. Real-time updates on events, politics, business and more.
January 27, 2024
StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note published on Wednesday. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Price Performance Shares of NAVB opened at $0.06 on Wednesday. Navidea Biopharmaceuticals has a one year low of $0.02 and a one year high of […]
January 26, 2024
Analysts at StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Free Report) in a research note issued on Wednesday. The brokerage set a “sell” rating on the stock. Navidea Biopharmaceuticals Stock Up 8.9 % Shares of NYSE NAVB opened at $0.06 on Wednesday. The stock has a fifty day moving average price […]
January 9, 2024
StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research report released on Monday. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance NYSE:NAVB opened at $0.05 on Monday. The firm’s fifty day moving average is $0.06 and its 200-day moving average is $0.07. Navidea Biopharmaceuticals […]
January 4, 2024
StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research report sent to investors on Sunday. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Price Performance Shares of Navidea Biopharmaceuticals stock opened at $0.05 on Friday. The business has a fifty day simple moving average of $0.06 […]
December 26, 2023
StockNews.com assumed coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research note released on Saturday morning. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Up 2.0 % Shares of NAVB opened at $0.06 on Friday. Navidea Biopharmaceuticals has a 12-month low of $0.02 and a 12-month high […]
December 23, 2023
Stock analysts at StockNews.com started coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Get Free Report) in a research report issued to clients and investors on Saturday. The brokerage set a “sell” rating on the stock. Navidea Biopharmaceuticals Stock Performance NAVB stock opened at $0.05 on Friday. The firm has a market cap of $5.39 […]
November 9, 2023
StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a report published on Sunday morning. The brokerage issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance Shares of NYSE NAVB opened at $0.05 on Friday. The company has a market cap of $5.00 million, a PE ratio of -0.17 […]
November 8, 2023
StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research report sent to investors on Sunday. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance NAVB stock opened at $0.05 on Friday. The company has a market capitalization of $5.00 million, a P/E ratio of -0.17 […]
November 1, 2023
StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a report issued on Saturday. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Price Performance NAVB opened at $0.05 on Friday. The stock has a market capitalization of $5.01 million, a price-to-earnings ratio of -0.17 and a beta of […]
September 29, 2023
StockNews.com began coverage on shares of Navidea Biopharmaceuticals (NYSE:NAVB – Free Report) in a research report released on Tuesday morning. The firm issued a sell rating on the stock. Navidea Biopharmaceuticals Stock Performance Shares of Navidea Biopharmaceuticals stock opened at $0.09 on Tuesday. The firm has a market capitalization of $9.32 million, a PE ratio […]